Previous close | 7.20 |
Open | 7.00 |
Bid | 5.50 |
Ask | 10.40 |
Strike | 40.00 |
Expiry date | 2024-06-21 |
Day's range | 7.00 - 7.20 |
Contract range | N/A |
Volume | |
Open interest | 188 |
IRVINE, Calif., May 23, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced today that it had filed a patent infringement lawsuit against Imperative Care, Inc. and Truvic Medical, Inc. (collectively, “Truvic”). The suit was filed in the United States District Court for the Northern District of California. Inari is seeking injunctive relief an
Inari Medical (NARI) continues to gain from its expanded product portfolio. However, continued loss at the operating level raises concern.
On May 16, 2024, Director William Hoffman of Inari Medical Inc (NASDAQ:NARI) executed a sale of 40,000 shares of the company's stock.